Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovation in the diagnosis, treatment, and prevention of cardiovascular disease.
Our progress would not be possible without our donor community. Help support our mission by giving today.
Some of the greatest inventions in the history of mankind have been made right here at Texas Heart Institute. Learn more about our history of firsts. Visit the Wallace Wilson Museum this summer. Read our Annual Report
THI is proud to announce its new membership into the National Academy of Inventors (NAI) to strengthen its commitment to inventorship and promote the translation of inventions to benefit society. Read Story
Our focus and resolve are as strong as they have been at any time in our proud history. We are deeply grateful for the decades of support from our local, national, and global community. THE NEXT FIRST in Cardiovascular Discovery is happening here . Read Our Annual Report
Signs of dementia include trouble learning and loss or decline in memory, language skills, visual perception, problem solving, self-management, ability to focus and paying attention. Vascular dementia, which occurs after a stroke (post-stroke dementia), is the second most common type of dementia. Just because you can identify with any of the above symptoms does not mean you have dementia. Read Dr. Stephanie Coulter’s recent Straight Talk Newsletter
Our physicians and researchers are dedicated to improving patient care for those suffering from heart disease, and the clinical trials underway at THI are vital to advancing the development of new medicines and therapies. View our current clinical trials.
Texas Heart Institute partnered with Make a Wish Foundation of New Jersey to help make a young woman’s wish come true. Watch this inspiring video to learn more about Micaela’s visit with some of the world’s best in cardiothoracic science!
The therapeutic potential of stem cells and cell therapy has captured the imagination of society and the medical community alike around the globe. Dr. Emerson Perin and Dr. James T. Willerson have led clinical trials focused on improving the treatment of heart failure, heart attacks, refractory angina, and peripheral arterial disease. Learn More
The Texas Heart Institute is proud to name Howard K. Schramm as Chief Administrative Officer. Learn More
Signs of dementia include trouble learning and loss or decline in memory, language skills, visual perception, problem solving, self-management, ability to focus and paying attention. Vascular dementia, which occurs after a stroke (post-stroke dementia), is the second most common type of dementia. Just because you can identify with any of the above symptoms does not mean you have dementia. Read Dr. Stephanie Coulter’s recent Straight Talk Newsletter
A left ventricular assist device (LVAD) allowed Otis Wimberly’s his failing heart and body to grow stronger and healthier before the stress of a transplant surgery. It was exactly what Otis needed before his heart completely stopped. Today he is preparing to sing at Jazz Fest in New Orleans with his family and celebrating life. Read Full Story
Our focus and resolve are as strong as they have been at any time in our proud history and we are laying the foundation for a promising future for patients suffering from cardiovascular disease. As we look ahead to another year of tremendous growth at THI, we continue to uphold the strong culture cultivated by Dr. Denton A. Cooley. Read Our 2018 Annual Report
Texas Heart Institute founder Dr. Denton A. Cooley performed the world’s first total artificial heart implant on April 4, 1969. The patient lived for nearly three days until a human heart was available for transplant. This was one of the most significant medical milestones for patients awaiting a new heart and paved the way for mechanical devices to be used as a bridge to transplant. Learn More
Our Office of Continuing Medical Education (CME) has been recognized as an accredited provider for over 35 years, and was recently awarded Accreditation with Commendation. We provide several comprehensive and innovative CME activities throughout the year, including conferences and symposia. Register for one of our upcoming offerings.
Texas Heart Institute – a proud member of WomenHeart’s National Hospital Alliance program – has partnered with WomenHeart to support women cardiac patients by serving as the host site for the WomenHeart Houston chapter’s support group meetings. Meetings are free of charge and open to all, regardless of where treatment is received. Learn More
Texas Heart Institute (THI) is pioneering some of the most groundbreaking cardiac arrhythmias research and management today in collaboration with institutions across the US. With a history of firsts in man devices, the next first in cardiac arrhythmia treatments is already happening at THI.
Risk assessments are used to determine your likelihood of developing disease in the future. Learn more below about the most critical numbers that impact your personal health and help your doctor assess your risk for both heart disease and stroke. Calculate Your BMI, Heart Health Tips and more…
En español Conozca sus cifras
Frequently Asked Patient Questions, located in the Heart Information Center, is a searchable tool that provides answers to thousands of commonly asked questions.
“I really just wanted to find opportunities around me to channel my passion. I care a lot about medicine and...
The pioneering spirit that has defined the Texas Heart Institute for over five decades is stronger than ever. We are...
Texas Heart Institute celebrated another outstanding match this year and welcomes eight exceptional young physicians to the Cardiovascular Disease Fellowship....
